Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China flag China · Delayed Price · Currency is CNY
5.36
-0.07 (-1.29%)
Nov 18, 2026, 3:04 PM CST

SHE:000952 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
254.76278.49307.18415.24431.35293.33
Cash & Short-Term Investments
254.76278.49307.18415.24431.35293.33
Cash Growth
-1.67%-9.34%-26.02%-3.74%47.05%-16.26%
Accounts Receivable
205.59256.81223.19297.42294.62197.61
Other Receivables
24.716.486.646.08-0.55
Receivables
230.3263.29229.83303.51299.7203.33
Inventory
211.42257.65322.03298.99221.47164.83
Other Current Assets
26.0645.0561.7866.9352.9747.47
Total Current Assets
722.54844.49920.821,0851,005708.96
Property, Plant & Equipment
1,0721,1721,5771,6371,1991,069
Long-Term Investments
53.0554.137.2835.244.1339.79
Other Intangible Assets
198.22203.82239.62216.91150.62154.72
Long-Term Deferred Tax Assets
22.0124.7820.7315.8827.7324.81
Long-Term Deferred Charges
4.274.819.1210.150.58-
Other Long-Term Assets
5.228.3418.8230.1342.2551.43
Total Assets
2,0772,3132,7943,0302,4702,049

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
137.37182.36121.22143.02178.6121.62
Accrued Expenses
19.7340.1441.9540.4332.2436.94
Short-Term Debt
674.1521.98344.24291.06197.13241.71
Current Portion of Long-Term Debt
-228132.8161.5158.9199.61
Current Portion of Leases
-0.721.051.591.20.84
Current Income Taxes Payable
9.180.030.370.221.852.61
Current Unearned Revenue
16.1211.396.47.075.4912.13
Other Current Liabilities
501.54401.7279.5220.9778.6124.82
Total Current Liabilities
1,3581,386927.51865.87654.03540.29
Long-Term Debt
123.6209.3393.75417.29301.5634.45
Long-Term Leases
0.580.991.352.253.191.65
Long-Term Unearned Revenue
10.7212.5713.315.6518.1221.04
Long-Term Deferred Tax Liabilities
0.350.360.50.690.920.33
Other Long-Term Liabilities
20.7976.11380.96335.320.340.33
Total Liabilities
1,5141,6861,7171,637978.17598.09

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
344346.75349.86353.86353.97344
Additional Paid-In Capital
354.75361.06377.12391.79391.09353.92
Retained Earnings
-106.14-46.23358.27653.56793.8764.58
Treasury Stock
--9.89-21.23-35.75-36.19-
Comprehensive Income & Other
4.062.080.93-0.01-0.02-0.03
Total Common Equity
596.67653.771,0651,3631,5031,462
Minority Interest
-33.44-26.9211.2629-10.83-11.67
Shareholders' Equity
563.24626.851,0761,3921,4921,451
Total Liabilities & Equity
2,0772,3132,7943,0302,4702,049

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
798.28960.99873.19873.69662378.26
Net Cash (Debt)
-543.51-682.5-566.01-458.45-230.65-84.93
Net Cash Growth
------
Net Cash Per Share
-1.57-1.96-1.61-1.30-0.65-0.25
Filing Date Shares Outstanding
344346.75349.86353.86353.97344
Total Common Shares Outstanding
344346.75349.86353.86353.97344
Working Capital
-635.49-541.83-6.69218.8351.46168.67
Book Value Per Share
1.731.893.043.854.254.25
Tangible Book Value
398.46449.95825.321,1471,3521,308
Tangible Book Value Per Share
1.161.302.363.243.823.80
Buildings
-1,0621,1411,196899.49839.29
Machinery
-1,3011,4781,370942.21840.98
Construction In Progress
-16.4133.160.96258.14204.47